Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Olaplex Holdings ( (OLPX) ).
On August 20, 2025, Olaplex Holdings, Inc. acquired Purvala Bioscience, a Boston-based biotech company, for $10.5 million. This acquisition marks OLAPLEX’s first since its inception over a decade ago, underscoring its commitment to innovation in the haircare industry. The integration of Purvala’s bioinspired technologies is expected to enhance OLAPLEX’s product offerings, potentially leading to the development of next-generation, science-backed products. This strategic move is anticipated to strengthen OLAPLEX’s position in the market and benefit its stylist community and consumers.
The most recent analyst rating on (OLPX) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Olaplex Holdings stock, see the OLPX Stock Forecast page.
Spark’s Take on OLPX Stock
According to Spark, TipRanks’ AI Analyst, OLPX is a Neutral.
Olaplex Holdings’ overall score reflects a mixed financial performance with strong gross margins but profitability challenges. The technical analysis suggests a neutral trend, while valuation metrics are weak due to recent losses. The earnings call provided some positive insights, and the recent board appointment is a strategic positive.
To see Spark’s full report on OLPX stock, click here.
More about Olaplex Holdings
OLAPLEX is a health and beauty company known for its innovative hair care products, particularly its Complete Bond Technology that protects and strengthens hair bonds. Founded in 2014, OLAPLEX has expanded its product line to serve professional, specialty retail, and direct-to-consumer channels globally.
Average Trading Volume: 1,225,434
Technical Sentiment Signal: Sell
Current Market Cap: $1.03B
For an in-depth examination of OLPX stock, go to TipRanks’ Overview page.